Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Platelets ; 29(8): 801-810, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29090621

RESUMO

Signaling mediated by purines is a widespread mechanism of cell-cell communication related to vasomotor responses and the control of platelet function in the vascular system. However, little is known about the involvement of this signaling as well as the role of reactive oxygen species (ROS) in the development of hypothyroidism. Therefore, the present study investigates changes in the purinergic system, including enzyme activities and expression in platelets, and oxidative profiles in patients with post-thyroidectomy hypothyroidism. The nucleoside triphosphate diphosphohydrolase 1 (NTPDase/CD39) expression in patients increased by 40%, and the adenosine triphosphate (ATP) or adenosine diphosphate (ADP) hydrolyzing activity increased by 82% and 70%, respectively. The activities of ecto-5´-nucleotidase and adenosine deaminase (ADA) also significantly enhanced (39% and 52%, respectively), which correlates with a 45% decrease in adenosine concentration. Furthermore, these patients demonstrated an increased production of ROS (42%), thiobarbituric acid reactive substances (TBARS) (115%), carbonyl protein (30%) and a decreased glutathione S-transferase (GST) activity (20%). This study demonstrates that hypothyroidism interferes with adenine nucleoside and nucleotide hydrolysis and this is correlated with oxidative stress, which might be responsible for the increase in ADA activity. This increase causes rapid adenosine deamination, which can generate a decrease in their concentration in the systemic circulation, which can be associated with the development of vascular complications.


Assuntos
Apirase/sangue , Plaquetas/enzimologia , Regulação Enzimológica da Expressão Gênica , Hipotireoidismo/sangue , Espécies Reativas de Oxigênio/sangue , Tireoidectomia , Difosfato de Adenosina/sangue , Trifosfato de Adenosina/sangue , Adulto , Idoso , Plaquetas/patologia , Feminino , Humanos , Hipotireoidismo/etiologia , Hipotireoidismo/patologia , Masculino , Pessoa de Meia-Idade
2.
Biomed Pharmacother ; 84: 1849-1857, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27832996

RESUMO

Diseases related to thyroid hormones have been extensively studied because affect a large number of individuals, and these hormones participate in the regulation of the whole organism homeostasis. However, little is known about the involvement of purinergic signaling related to oxidative stress in hypothyroidism and possible therapeutic adjuncts for treatment of this disorder. Thus, the present study investigates the effects of quercetin on NTPDase, 5'-nucleotidase and adenosine deaminase activities, platelet aggregation and oxidative profile in platelets of rats with methimazole (MMI)-induced hypothyroidism. Methimazole at a concentration of 20mg/100mL was administered for 90days. From the second month the animals received quercetin 10 or 25mg/kg for 60days. Results showed that: Ecto-5'-nucleotidase activity decreased in methimazole/water group and the treatment with quercetin 25mg/kg decreased NTPDase, 5'-nucleotidase and adenosine deaminase activities. Moreover, platelet aggregation increased in methimazole/water group. Lipid peroxidation increased while superoxide dismutase and catalase activities decreased, but, interestingly, the treatment with quercetin reversed these changes. These results demonstrated that quercetin modulates adenine nucleotide hydrolysis decreasing the ADP formation and adenosine deamination. At the same time quercetin improves the oxidative profile, as well as reduces platelet aggregation, which together with the modulation in the nucleotides levels can contribute to the prevention of platelet disorders.


Assuntos
Adenosina Desaminase/sangue , Antioxidantes/farmacologia , Plaquetas/efeitos dos fármacos , Hipotireoidismo/tratamento farmacológico , Proteínas Oncogênicas/sangue , Estresse Oxidativo/efeitos dos fármacos , Inibidores da Agregação Plaquetária/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Quercetina/farmacologia , Nucleotídeos de Adenina/sangue , Animais , Plaquetas/enzimologia , Catalase/sangue , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Hidrólise , Hipotireoidismo/sangue , Hipotireoidismo/induzido quimicamente , Hipotireoidismo/enzimologia , Cinética , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Proteínas de Membrana/sangue , Metimazol , Ratos Wistar , Superóxido Dismutase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA